February 2nd 2024
Successful test results
EYE-GO is continuously improving and testing MistGo®.
We are proud to report that we during 2023 have completed multiple successful tests:
- Micro-dosing (conducted by Copenhagen University Hospital)
Micro-dosing eye medication is as safe and efficacious as conventional eye drops.
MistGo® micro-dosing mist technology, with only 6 μL dose volume, provides a comparable pupil dilation using Tropicamide 1%, as when using a conventional eyedrop applicator with approximately 30 μL dose volume.
- Sterility (conducted by Danish Technological Institute)
MistGo® is designed to provide an effective barrier to microbial ingress and is a delivery device suitable for preservative-free eye medications.
- User study (conducted by Design Psychology)
MistGo® offers patients significant advantages over conventional bottles.
The design of an eye drop bottle leads many patients to administer their medication incorrectly.
MistGo® is an innovative alternative designed to help patients administer their eye medication in a more precise and user-friendly way. The better user experience translates into higher patient compliance, healthier eyes, and higher quality of life for patients.
- Performance (conducted by EYE-GO)
MistGo® has a large performance window and is able to administer different kinds of topical treatments, even the ones with high viscosity and stickiness.
